BNKK · XBRL financial data

Bonk financial statements, every quarter

The same tables from 13 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal quarters (BNKK's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Revenue	12	133*	171	710	110	182*	42	45	1,515	515*	786	793
Cost of revenue	46	179*	2,383	505	402	599*	21	21	1,481	1,169*	744	772
Gross profit	(35)	—	(2,213)	206	(292)	—	21	24	543	—	3,593	391
Research and development	61*	3*	141	120	10	0*	9	7	9	0*	0	0*
General and administrative	4,091	5,484*	12,957	8,619	11,348	6,688*	5,411	4,364	17,216	8,735*	2,219	2,425
Total operating expenses	4,091	5,484*	12,957	8,619	11,348	6,688*	5,411	—	—	—	—	—
Interest income	—	—	—	—	—	year only	11	—	—	year only	8	—
Interest expense	0*	23*	10	9*	8*	7*	92	115	133	—	—	—
Other income (expense)	(2,427)	(7)*	—	—	—	(4,774)*	(25)	25	—	year only	14	(0)*
Net income (loss)	(7,738)	(5,677)*	(15,675)	(8,274)	(11,929)	(13,532)*	(5,327)	13,375	(33,581)	(42,653)*	(1,829)	(6,055)
Earnings per share, basic USD per share	(0.26)	—	(0.33)	(0.16)	(0.21)	(0.22)*	(0.08)	0.16	(0.22)	—	(0.23)	(0.76)
Earnings per share, diluted USD per share	(0.26)	—	(0.33)	(0.16)	(0.21)	(0.22)*	(0.08)	0.09	—	—	—	(0.76)
Weighted average shares, basic thousands of shares	29,836	—	47,436	51,735	55,931	62,558*	69,258	83,175	150,285	—	7,918	8,016
Weighted average shares, diluted thousands of shares	29,836	—	47,436	51,735	55,931	62,558*	69,258	150,244	—	—	—	8,016

† Share count changed about 1/23 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Balance sheet

CSV

Fiscal quarters (BNKK's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Cash and cash equivalents	4,388	3,833	2,046	3,224	1,360	349	329	467	8,960	2,278	729	214
Marketable securities	2,281	843	243	55	55	55	55	55	55	55	55	—
Accounts receivable	3	6	5	162	5	84	29	120	358	90	730	42
Inventory	94	796	404	739	524	234	339	841	891	949	757	572
Total current assets	8,166	7,691	4,344	5,949	3,476	2,580	4,031	21,943	58,494	6,042	6,550	4,270
Property and equipment, net	31	28	26	47	103	94	85	86	75	66	51	43
Right-of-use asset	522	479	436	391	346	300	252	276	46	19	—	—
Goodwill	—	0	0	—	—	0	—	12,594	12,594	14,148	14,148	14,148
Total assets	11,331	12,709	9,215	10,695	8,375	7,338	8,695	42,067	81,042	40,973	38,388	31,591
Accounts payable	1,690	1,494	1,054	1,106	1,266	2,219	2,842	6,158	3,062	2,477	2,401	2,079
Accrued liabilities	89	60	265	405	305	234	191	—	—	—	—	—
Total current liabilities	4,263	3,587	3,397	3,371	1,827	9,397	9,185	18,927	5,522	5,977	5,104	4,067
Lease liability, non-current	359	305	247	189	170	114	52	52	—	—	—	—
Total liabilities	4,622	3,892	3,644	4,225	1,997	9,511	9,237	18,979	5,522	5,977	5,104	4,067
Accumulated deficit	(60,004)	(65,681)	(81,355)	(89,629)	(101,559)	(115,090)	(120,417)	(107,258)	(140,840)	(183,492)	(185,321)	(191,375)
Total stockholders' equity	6,709	8,817	5,571	6,469	6,378	(2,173)	(543)	23,088	75,519	34,996	33,284	27,524
Total liabilities and equity	11,331	12,709	9,215	10,695	8,375	7,338	8,695	42,067	81,042	40,973	38,388	31,591
Common shares outstanding (cover page) thousands of shares	39,818	49,220	51,703	52,016	61,138	74,452	75,177	144,867	183,976	7,851	8,001	8,001

† Share count changed about 1/23 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Cash flows

CSV

Fiscal quarters (BNKK's year ends in late December)

In thousands of dollars	Q3 FY23Sep 30, 2023	Q4 FY23Dec 31, 2023	Q1 FY24Mar 31, 2024	Q2 FY24Jun 30, 2024	Q3 FY24Sep 30, 2024	Q4 FY24Dec 31, 2024	Q1 FY25Mar 31, 2025	Q2 FY25Jun 30, 2025	Q3 FY25Sep 30, 2025	Q4 FY25†Dec 31, 2025	Q1 FY26Mar 31, 2026	Q2 FY26Jun 30, 2026
Net income (loss)	(7,738)	(5,677)*	(15,675)	(8,274)	(11,929)	(13,532)*	(5,327)	13,375	(33,581)	(42,653)*	(1,829)	(6,055)
Stock-based compensation	—	year only	663	—	—	year only	959	—	—	year only	—	—
Depreciation and amortization	68*	102*	105	105*	109*	111*	111	111*	202*	231*	209	165*
Net cash from operating activities	(2,937)*	(5,481)*	(6,388)	(5,713)*	—	year only	(4,628)	(1,654)*	—	year only	(1,942)	(2,226)*
Purchases of property and equipment	—	year only	—	—	—	year only	—	—	—	—	—	—
Net cash from investing activities	1,913*	(1,692)*	809	71*	(633)*	(253)*	(363)	121*	6,534*	(467)*	392	1,812*
Proceeds from issuing common stock	—	—	—	—	—	—	—	—	18,646*	0*	—	—
Net cash from financing activities	2,640*	6,670*	3,792	6,819*	4,209*	788*	4,972	1,671*	14,738*	0*	—	—
Net change in cash	2,069*	(554)*	(1,787)	1,177*	(1,863)*	(1,012)*	(20)	138*	8,493*	(6,682)*	(1,549)	(514)*

† Share count changed about 1/23 in the period ending 2025-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Compare with peers

SIC 2844 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2844 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Bonk	214	793	(2,226)*	8.0M	0.1 quarters	Q2 FY26 10-QJun 30, 2026
Karbon-X	335	344	(1,198)	109.2M	—	Q1 FY27 10-Q/AAug 31, 2026
Bowen Acquisition	4.1	not reported	(2.9)*	2.5M	1.4 quarters	Q2 FY26 10-QJun 30, 2026
United Guardian	2,391	not reported	1,520*	4.6M	—	Q2 FY26 10-QJun 30, 2026
Solesence	1,046	15,332	191*	70.6M	—	Q2 FY26 10-QJun 30, 2026
Axil Brands	7,929	6,090	3,763	6.8M	—	Q1 FY27 10-QAug 31, 2026
DSwiss	258	512	50*	206.9M	—	Q2 FY26 10-QJun 30, 2026
Zone Frontier	15,435	886*	(3,342)*	508.8M	4.6 quarters	Q4 FY26 10-KJun 30, 2026
Scientist Home Future Health	14	212	(45)*	23.7M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.